Immune reconstitution of HLA-A*0201/BMLF1- and HLA-A*1101/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell trans...

Por Zhou, Ling, Lu, Dao-pei
Publicado no Virol J (2019)

Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical h...

Por Zhou, Ling, Gao, Zhi-yong, Lu, Dao-pei
Publicado no Ann Hematol (2020)

Epigenetic modification and preliminary investigation of the mechanism of the immune evasion of HL-60 cells

Por LIU, JIN HONG, BIAN, YONG MEI, XIE, YI, LU, DAO PEI
Publicado no Mol Med Rep (2015)

Sequential allogeneic and autologous CAR-T–cell therapy to treat an immune-compromised leukemic patient

Por Zhang, Jian-Ping, Zhang, Rui, Tsao, Shih-Ting, Liu, Yu-Chen, Chen, Xiaochuan, Lu, Dao-Pei, Castillo, Paul, Chang, Lung-Ji
Publicado no Blood Adv (2018)

The outcomes of family haploidentical hematopoietic stem cell transplantation in hematological malignancies are not associated with patient age

Por Dong, Lujia, Wu, Tong, Gao, Zhi-Yong, Zhang, Mei-Jie, Kan, Fangyu, Spellman, Stephen R., Tan, Xi-You, Zhao, Yan-Li, Wang, Jing-Bo, Lu, Dao-Pei, Miklos, David, Petersdorf, Effie, Fernandez-Vina, Marcelo, Lee, Stephanie J.
Publicado em 2010